Related Experiment Video

Updated: Aug 10, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Published on: February 9, 2011

Adverse drug reactions leading to hospitalization in children

M W McKenzie, G L Marchall, M L Netzloff

    The Journal of Pediatrics
    |September 1, 1976
    PubMed

    Insights

    Adverse drug reactions led to 2.0% of pediatric hospital admissions over three years. Antineoplastic drugs were the most common cause of these severe reactions, with some resulting in death.

    Area of Science:

    • Pediatric pharmacology
    • Clinical epidemiology
    • Drug safety surveillance

    Background:

    • Prospective epidemiologic surveillance is crucial for understanding drug safety in vulnerable populations.
    • Pediatric populations may exhibit unique responses to medications, necessitating specific safety monitoring.
    • Adverse drug reactions (ADRs) represent a significant public health concern, particularly in hospitalized patients.

    Observation:

    • Over a three-year period, 72 out of 3,556 pediatric medical admissions (2.0%) were attributed to adverse drug reactions.
    • Antineoplastic agents were identified as the most frequent cause of drug-related hospital admissions in children.
    • A substantial proportion of these reactions, approximately 40%, were classified as severe.

    Findings:

    • The study identified a 2.0% incidence of adverse drug reactions leading to pediatric hospitalization.
    • Antineoplastic drugs were the primary culprits for drug-induced admissions in the pediatric cohort.
    • Severe adverse drug reactions were common, and four cases were fatal, highlighting the potential severity of drug toxicity in children.

    Implications:

    • Findings underscore the need for enhanced monitoring and risk management strategies for antineoplastic drugs in pediatric care.
    • This data emphasizes the importance of pharmacovigilance systems in detecting and mitigating pediatric adverse drug events.
    • Improved drug safety protocols are essential to reduce the burden of severe and fatal adverse drug reactions in children.

    Related Concept Videos

    Factors Affecting Drug Response: Overview01:21

    Factors Affecting Drug Response: Overview

    When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
    Pharmacovigilance01:19

    Pharmacovigilance

    Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
    This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
    In some cases, there...
    Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

    Pharmacokinetics in Pediatric Patients: Drug Excretion

    In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
    Drug Toxicity: Overview01:00

    Drug Toxicity: Overview

    Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
    Drug Toxicity: Risk factors01:24

    Drug Toxicity: Risk factors

    Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
    Pharmaceutical Poisoning: Potential Scenarios01:26

    Pharmaceutical Poisoning: Potential Scenarios

    Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...